Abbott Laboratories
Abbott Laboratories (ABT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ABT · as of Sep 30, 2025
Ownership Breakdown
3,255
Institutional Holders
▼ 10 vs Q2
$181.41B
Total Inst. Value
▼ $124.15B vs Q2
1.74B
Shares Outstanding
freeFloat 99.32%
1.35B
13F Shares Held
▼ 21.79M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ABT largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 173.15M | 9.90% | 9.90% | $23.19T | Nov 7, 2025 | ▲ 353.5K |
BLACKROCK, INC. pharmaceutical preparations | 141.56M | 8.09% | 8.09% | $18.96T | Nov 12, 2025 | ▲ 272.9K |
STATE STREET CORP pharmaceutical preparations | 78.23M | 4.47% | 4.47% | $10.48T | Nov 14, 2025 | ▼ 128.3K |
CAPITAL INTERNATIONAL INVESTORS pharmaceutical preparations | 61.61M | 3.52% | 3.52% | $8.25T | Nov 13, 2025 | ▲ 1.48M |
CAPITAL RESEARCH GLOBAL INVESTORS pharmaceutical preparations | 38.77M | 2.22% | 2.22% | $5.19T | Nov 13, 2025 | ▼ 3.00M |
MORGAN STANLEY pharmaceutical preparations | 38.63M | 2.21% | 2.21% | $5.17T | May 27, 2026 | ▲ 3.43M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 38.54M | 2.20% | 2.20% | $5.14T | Nov 12, 2025 | ▲ 248.8K |
JPMORGAN CHASE & CO pharmaceutical preparations | 29.38M | 1.68% | 1.68% | $3.94T | Nov 26, 2025 | ▼ 9.92M |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 23.25M | 1.33% | 1.33% | $3.11T | Nov 14, 2025 | ▼ 1.80M |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 20.81M | 1.19% | 1.19% | $2.79T | Feb 3, 2026 | ▼ 889.7K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
27
Increased
+36.17M shares0
New Positions
first time holders22
Decreased
−27.81M shares0
Sold Out
fully exitedNet shares change (top 50)
+8.36M
+36.17M / −27.81M
Net new holders
+5
0 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ABT insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
19
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Moreland Mary K EXECUTIVE VICE PRESIDENT | Apr 28, 2026 | I-Discretionary | 5,314 | $94.41 | $501.7K | 17.2K | Form 4 ↗ |
Conroy Kevin T director | Apr 24, 2026 | Award | 2,286 | — | — | 133.7K | Form 4 ↗ |
Stratton John G director | Apr 24, 2026 | Award | 2,286 | — | — | 21.3K | Form 4 ↗ |
STARKS DANIEL J director | Apr 27, 2026 | Purchase | 10,000 | $92.65 | $926.5K | 6.75M | Form 4 ↗ |
STARKS DANIEL J director | Apr 24, 2026 | Award | 2,286 | — | — | 6.74M | Form 4 ↗ |
STARKS DANIEL J director | Apr 24, 2026 | Award | 7,105 | $91.86 | $652.7K | 7.1K | Form 4 ↗ |
Roman Michael F director | Apr 24, 2026 | Award | 2,286 | — | — | 10.8K | Form 4 ↗ |
O'Grady Michael director | Apr 24, 2026 | Award | 2,286 | — | — | 7.6K | Form 4 ↗ |
O'Grady Michael director | Apr 24, 2026 | Award | 5,929 | $91.86 | $544.6K | 5.9K | Form 4 ↗ |
McKinstry Nancy director | Apr 24, 2026 | Award | 2,286 | — | — | 41.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Abbott Laboratories (ABT) is primarily owned by institutional investors, who hold approximately 77.8% of total shares outstanding. Company insiders own approximately 0.68%, while retail and public investors account for the remaining 21.54%.
The largest institutional shareholder of Abbott Laboratories is VANGUARD GROUP INC, holding approximately 173.15 million shares — equal to 9.90% of outstanding shares — as of September 30, 2025.
A total of 3,255 institutional investors currently hold ABT stock, with a combined institutional value of approximately $181.41 billion as of the most recent 13F filing period.
Frequently asked questions
ABT ownershipAbbott Laboratories (ABT) is primarily owned by institutional investors, who hold approximately 77.8% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.90% stake. Company insiders hold 0.68%. Data sourced from SEC Form 13F as of September 30, 2025.